HB 1661

  • Pennsylvania House Bill
  • 2023-2024 Regular Session
  • Introduced in House
  • Passed House Oct 04, 2023
  • Passed Senate May 01, 2024
  • Signed by Governor May 15, 2024

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances; and providing for secure storage of xylazine.

Votes


Actions


May 15, 2024

House

Approved by the Governor

House

Act No. 17 of 2024

May 08, 2024

House

Presented to the Governor

May 07, 2024

House

Signed in Senate

May 06, 2024

House

Re-reported on concurrence, as committed

House

Signed in House

House

House concurred in Senate amendments

May 01, 2024

Senate

Third consideration and final passage

House

Referred to Rules

Apr 30, 2024

Senate

Amended on third consideration

Mar 18, 2024

Senate

Re-reported as committed

Nov 15, 2023

Senate

Re-referred to Appropriations

Nov 14, 2023

Senate

Second consideration

Nov 13, 2023

Senate

First consideration

Senate

Reported as committed

Oct 13, 2023

Senate

Referred to Agriculture & Rural Affairs

Oct 04, 2023

House

Re-reported as committed

House

Third consideration and final passage

Oct 03, 2023

House

Second consideration, with amendments

House

Re-committed to Appropriations

Oct 02, 2023

House

Removed from table

Sep 27, 2023

House

Reported as committed

House

Laid on the table

House

First consideration

Sep 07, 2023

House

Referred to Agriculture & Rural Affairs

Bill Text

Bill Text Versions Format
Printer's No. PN3026 MSWORD HTML PDF
Printer's No. PN2091 MSWORD HTML PDF
Senate Amendment A04198 MSWORD HTML PDF
Printer's No. PN1963 MSWORD HTML PDF
House Amendment A02363 MSWORD HTML PDF

Related Documents

Document Format
Senate Fiscal Note PDF
House Fiscal Note PDF PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.